In low- and intermediate-risk MDS patients, an increased TNF-α production upon stimulation with LPS has been reported as well, together with an increased proportion of intermediate monocytes (CD14bright/CD16+) and a lower proportion of classical monocytes (CD14bright/CD16−) [32]. Here, TNF is linked to myelodysplastic syndrome.